Davis v. Secretary of Health and Human Services

United States Court of Federal Claims·Decided June 27, 2022·No. 18-1763·Unpublished

Opinion

Sn the Gunited States Court of Federal Claing

OFFICE OF SPECIAL MASTERS Filed: June 1, 2022

* Kk * CF Kk * ke CK Kk Kk Kk OK KK OK

TENEISHA C. DAVIS, * UNPUBLISHED * Petitioner, * No. 18-1763V * V. * Special Master Dorsey * SECRETARY OF HEALTH * Decision Based on Stipulation; AND HUMAN SERVICES, * Influenza (“Flu”) Vaccine; * Guillain-Barré Syndrome (“GBS”). Respondent. * * * Kk ok ok Ok ok Kk Kk ok OK OK OK KO *

Jimmy A. Zgheib, Zgheib Sayad, P.C., White Plains, NY, for Petitioner. Christine M. Becer, U.S. Department of Justice, Washington, DC, for Respondent.

DECISION BASED ON STIPULATION'

On November 15, 2018, Teneisha C. Davis (“Petitioner”) filed a petition in the National Vaccine Injury Compensation Program.” Petitioner alleged that as a result of an influenza (“flu”) vaccine on October 16, 2017, she developed Guillain-Barré syndrome (“GBS”). Petition at 1 (ECF No. 1).

On June 1, 2022, the parties filed a stipulation recommending an award of compensation to Petitioner. Stipulation (ECF No. 70). Respondent denies that the flu vaccine caused Petitioner to suffer GBS or any other injury or her current condition. Id. at {| 6. Nevertheless,

' Because this Decision contains a reasoned explanation for the action in this case, the undersigned is required to post it on the United States Court of Federal Claims’ website in accordance with the E-Government Act of 2002. 44 U.S.C. § 3501 note (2012) (Federal Management and Promotion of Electronic Government Services). This means the Decision will be available to anyone with access to the Internet. In accordance with Vaccine Rule 18(b), Petitioner has 14 days to identify and move to redact medical or other information, the disclosure of which would constitute an unwarranted invasion of privacy. If, upon review, the undersigned agrees that the identified material fits within this definition, the undersigned will redact such material from public access.

* The National Vaccine Injury Compensation Program is set forth in Part 2 of the National Childhood Vaccine Injury Act of 1986, Pub. L. No. 99-660, 100 Stat. 3755, codified as amended, 42 U.S.C. §§ 300aa-1 to -34 (2012) (“Vaccine Act” or “the Act”). All citations in this Decision to individual sections of the Vaccine Act are to 42 U.S.C. § 300aa. the parties agree to the joint stipulation, attached hereto as Appendix A. The undersigned finds the stipulation reasonable and adopts it as the decision of the Court in awarding damages, on the terms set forth therein.

The parties stipulate that Petitioner shall receive the following compensation:

(1) A lump sum of $417,265.15, which amount represents compensation for first year life care expenses, lost earnings, pain and suffering, and past unreimbursable expenses in the form of a check payable to Petitioner; and

(2) An amount sufficient to purchase the annuity contract described in paragraph 10 of the stipulation, paid to the life insurance company from which the annuity will be purchased.

This amount represents compensation for all damages that would be available under 42 U.S.C. § 300aa-15(a). Stipulation at J 8.

The undersigned approves the requested amount for Petitioner’s compensation. Accordingly, an award should be made consistent with the stipulation.

In the absence of a motion for review filed pursuant to RCFC Appendix B, the Clerk of Court SHALL ENTER JUDGMENT in accordance with the terms of the parties’ stipulation.*

IT IS SO ORDERED.

s/Nora Beth Dorsey Nora Beth Dorsey

Special Master

> Pursuant to Vaccine Rule 11(a), entry of judgment is expedited by the parties’ joint filing of notice renouncing the right to seek review. IN THE UNITED STATES COURT OF FEDERAL CLAIMS OFFICE OF SPECIAL MASTERS

TENEISHA C. DAVIS, ) ) Petitioner, ) Vv. ) ) No. 18-1763V SECRETARY OF HEALTH ) Special Master Dorsey AND HUMAN SERVICES, ) ECF ) Respondent. ) ) STIPULATION

The parties hereby stipulate to the following matters:

1. Teneisha C. Davis, petitioner, filed a petition for vaccine compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. §§ 300aa-10 to -34 (the “Vaccine Program”). The petition seeks compensation for injuries allegedly related to petitioner’s receipt of the influenza (“flu”) vaccine, which vaccine is contained in the Vaccine Injury Table (the “Table”), 42 C.F.R. § 100.3 (a).

2. Petitioner received her vaccination on October 16, 2017.

3. The vaccination was administered within the United States.

4. Petitioner alleges that she suffered from Guillain-Barré syndrome (“GBS”) as a result of receiving the flu vaccine, and that she experienced the residual effects of this injury for more than six months.

5. Petitioner represents that there has been no prior award or settlement of a civil action for damages on her behalf as a result of her condition.

6. Respondent denies that the flu vaccine caused petitioner to suffer from GBS or any

other injury or her current condition. 7. Maintaining their above-stated positions, the parties nevertheless now agree that the issues between them shall be settled and that a decision should be entered awarding the compensation described in paragraph 8 of this Stipulation.

8. As soon as practicable after an entry of judgment reflecting a decision consistent with the terms of this Stipulation, and after petitioner has filed an election to receive compensation pursuant to 42 U.S.C. § 300aa-21(a)(1), the Secretary of Health and Human Services will issue the following vaccine compensation payments:

a. A lump sum of $417,265.15, which amount represents compensation for first year life

care expenses, lost earnings, pain and suffering, and past unreimbursable expenses in the

form of a check payable to petitioner; and

b. An amount sufficient to purchase the annuity contract described in paragraph 10

below, paid to the life insurance company from which the annuity will be purchased (the

“Life Insurance Company”).

These amounts represent compensation for all damages that would be available under 42 U.S.C. §300aa-15(a).

9. The Life Insurance Company must have a minimum of $250,000,000 capital and surplus, exclusive of any mandatory security valuation reserve. The Life Insurance Company must have one of the following ratings from two of the following rating organizations:

a. A.M. Best Company: A++, A+, A+g, Atp, Atr, or Ats;

b. Moody’s Investor Service Claims Paying Rating: Aa3, Aa2, Aal, or Aaa;

C: Standard and Poor’s Corporation Insurer Claims-Paying Ability Rating: AA-, AA, AA+, or AAA;

d. Fitch Credit Rating Company, Insurance Company Claims Paying Ability Rating: AA-, AA, AA+, or AAA.

10. The Secretary of Health and Human Services agrees to purchase an annuity contract

from the Life Insurance Company for the benefit of petitioner, Teneisha C.

Free access — add to your briefcase to read the full text and ask questions with AI

Davis v. Secretary of Health and Human Services, (uscfc 2022).

Davis v. Secretary of Health and Human Services (Davis v. Secretary of Health and Human Services) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

§ 300aa
42 U.S.C. § 300aa
§ 300aa-
42 U.S.C. § 300aa-
§ 300aa-1
42 U.S.C. § 300aa-1
§ 300aa-10
42 U.S.C. § 300aa-10
§ 300aa-15
42 U.S.C. § 300aa-15(a)
§ 300aa-21
42 U.S.C. § 300aa-21(a)(1)
Purposes
44 U.S.C. § 3501
§ 300a
42 U.S.C. § 300a